This year, Neurotar will feature its proprietary research devices and the new types of research that they enable. Katja Karelina (CEO) and Leonard Khiroug (CSO) are happy to talk to investors about our plans to grow the company, and to partners interested in advancing their biologics’ development through in vivo two-photon imaging –based screening. We […] Read more »
Archive by year: 2014
Neurotar attends Swiss Society of Cosmetic Chemists Congress in Davos on January 27-29, 2014
Leonard Khirug (CSO) presents Skinvivo service offering for cosmetic product development with an emphasis on the newly developed readout — measuring advanced glycation end-products (AGE) in the skin of human volunteers.
Neurotar’s CSO lectures on awake imaging at the University of Tübingen in Germany on January 24, 2014
The lecture features Neurotar’s proprietary Mobile HomeCage device, which enables imaging in awake and freely moving animals. Leonard Khiroug (CSO) shares the experiences of using the device for in vivo two-photon imaging and maps out other application areas.